Stage 3 breast cancer means cancer has spread extensively within the breast and to nearby lymph nodes but has not reached distant organs like the lungs, liver, or bones. It’s sometimes called “locally advanced” breast cancer. About 28% of breast cancers are diagnosed at this regional stage, and the five-year relative survival rate is 87.2%, based on data from the National Cancer Institute’s SEER program.
What Makes It Stage 3
Staging depends on three factors: the size of the tumor (T), whether cancer has reached nearby lymph nodes (N), and whether it has spread to distant parts of the body (M). In stage 3, distant spread hasn’t happened, but the cancer has moved beyond the breast in significant ways. That can mean a large tumor, cancer in multiple lymph nodes, or growth into the chest wall or skin of the breast.
Stage 3 is divided into three substages, each reflecting a different pattern of spread.
Stage 3A
In stage 3A, one of the following is true: the cancer has reached 4 to 9 lymph nodes under the arm or near the breastbone, regardless of tumor size. Or the tumor is larger than 5 centimeters and cancer has spread to 1 to 3 lymph nodes. Or the tumor is larger than 5 centimeters and small clusters of cancer cells (between 0.2 and 2 millimeters) are found in lymph nodes. The key feature of 3A is significant lymph node involvement or a large tumor with limited node spread, but no growth into the chest wall or skin.
Stage 3B
Stage 3B means the cancer has grown into the chest wall (the muscles, fat, and bones that protect the chest organs), into the skin of the breast, or both. The tumor can be any size. Up to 9 nearby lymph nodes may contain cancer. This substage also includes inflammatory breast cancer, which can cause visible skin changes without a distinct lump.
Stage 3C
Stage 3C involves the most extensive lymph node spread. Cancer has reached 10 or more lymph nodes under the arm, lymph nodes above or below the collarbone, or both the underarm and breastbone lymph nodes. The tumor itself can be any size. In some cases, it may also involve the chest wall or skin.
Signs and Symptoms
Stage 3 breast cancer often produces noticeable physical changes because of how far the cancer has spread locally. You might feel a breast lump that seems fixed to the chest wall and doesn’t move freely when you press on it. A large, hard lump in the armpit that feels stuck in place is another common sign, caused by cancer filling the lymph nodes.
Skin changes are a hallmark of the more advanced substages. The skin of the breast may thicken and dimple, taking on the texture of an orange peel (a pattern doctors call peau d’orange). In some cases, the skin breaks down into open sores or ulcers. Inflammatory breast cancer, which falls under stage 3B, causes a large area of the breast to become red, swollen, and warm. It can develop quickly and often doesn’t form a traditional lump, which makes it harder to catch on a mammogram. A lump at the base of the neck can also signal that cancer has reached the lymph nodes above the collarbone, a feature of stage 3C.
How Stage 3 Is Diagnosed
Confirming stage 3 requires both a tissue biopsy and imaging to map how far the cancer has spread. A biopsy of the breast tumor and affected lymph nodes establishes the diagnosis. From there, imaging tests determine the full extent of disease and rule out distant spread to organs.
MRI is the most sensitive tool for evaluating the breast itself. It outperforms mammography and ultrasound at detecting cancer that has spread to multiple areas within the same breast, to different sections of the breast, or to the opposite breast. MRI picks up cancers in the other breast that mammography and ultrasound miss in roughly 3% of women with a known cancer on one side. CT scans and bone scans are typically used to check the lungs, liver, and bones, confirming the cancer hasn’t spread distantly (which would reclassify it as stage 4).
How Stage 3 Is Treated
Treatment for stage 3 breast cancer almost always involves multiple steps: chemotherapy, surgery, and radiation, often in that specific order.
Chemotherapy usually comes first, before surgery. This approach, called neoadjuvant chemotherapy, shrinks the tumor so surgery can be less extensive. In some cases, a tumor that would have required removing the entire breast can be reduced enough to allow breast-conserving surgery, where only the tumor and surrounding tissue are removed. How well the cancer responds to this initial chemotherapy also gives your medical team important information about the biology of your cancer and guides further treatment decisions.
Surgery follows chemotherapy. Depending on how much the tumor has shrunk and how extensive the original cancer was, this may be a lumpectomy (removing the tumor area) or a mastectomy (removing the breast). Lymph nodes containing cancer are also removed during surgery.
Radiation therapy comes after surgery. It targets the chest wall and lymph node areas to destroy any remaining cancer cells. For patients who had breast-conserving surgery, radiation is standard. Many patients who had a mastectomy also receive radiation given the advanced local spread typical of stage 3.
Additional treatments depend on the specific biology of the cancer. Hormone-sensitive cancers are treated with hormone-blocking therapy that continues for years after the initial treatment is complete. Cancers that overproduce the HER2 protein are treated with drugs that specifically target that protein. Triple-negative breast cancers, which lack these targets, may be treated with immunotherapy alongside chemotherapy.
Survival and Recurrence
The five-year relative survival rate for regional-stage breast cancer is 87.2%. This means that people diagnosed at this stage are about 87% as likely to be alive five years later compared to people in the general population without breast cancer. This number reflects outcomes across all substages and cancer subtypes, so individual prognosis varies based on the specific biology of the tumor, how well it responds to initial treatment, and other health factors.
Recurrence remains a concern after treatment. A study published in the Journal of the National Cancer Institute found that the residual risk of recurrence in the five years following completion of adjuvant therapy was 13% for stage 3 patients, compared to 11% for stage 2 and 7% for stage 1. “Recurrence” in this context includes cancer returning in the breast or nearby lymph nodes, spread to distant organs, or a new primary breast cancer. Because of this ongoing risk, follow-up care after treatment involves regular physical exams, mammograms, and monitoring for symptoms over a period of many years.
Inflammatory Breast Cancer
Inflammatory breast cancer deserves special mention because it’s staged and diagnosed differently from other breast cancers. It accounts for only 1% to 5% of all breast cancers but is automatically classified as at least stage 3B because of how it grows. Rather than forming a distinct lump, it blocks tiny lymph vessels in the skin, causing a third or more of the breast to become red, swollen, and warm. The skin may look pitted or ridged.
Because it doesn’t produce a typical mass, inflammatory breast cancer often doesn’t show up on a mammogram. It can also be mistaken for a breast infection, which may delay diagnosis. It tends to grow and spread faster than other forms of breast cancer, so it’s treated aggressively with chemotherapy before surgery, followed by mastectomy and radiation.